Condition: Stenoses · Dyspnea · Sponsor: University Hospital, Toulouse
The placement of an endoprosthesis in the airways leads to rapid and dramatic clinical improvement in the majority of cases of central airway obstruction. However, the limited diversity of device shapes available on the market is a major limitation, as these devices are poorly adapted, or not adapted at all, to the patient's anatomy. The main consequences of this lack of congruity are stent migration and granulomatous inflammatory reactions. The investigators hypothesized that personalized endoprostheses could significantly reduce the complication rate and improve tolerability. In this randomized controlled trial, the investigators propose to evaluate whether personalized endoprostheses allow for better management of non-malignant central airway stenoses by comparing this new approach to standard care.
This description comes directly from the study's public registry record.
Audrey TOMASIK · +33 (0) 5 61 77 85 97 · tomasik.a@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Hôpital Marie Lannelongue / Institut Gustave Roussy | Le Plessis-Robinson, France | — |
| Institut Cœur Poumon - CHU Lille | Lille, France | — |
| CHU Limoges | Limoges, France | — |
| CHRU Strasbourg | Strasbourg, France | — |
| Hôpital Foch | Suresnes, France | — |
| Larrey Hospital | Toulouse, France | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.